GPR56/ADGRG1 is associated with response to antidepressant treatment
Raoul Belzeaux(Centre National de la Recherche Scientifique), Gustavo Turecki(Douglas Mental Health University Institute), Bruno Giros(Centre National de la Recherche Scientifique), Marcelo T. Berlim(Douglas Mental Health University Institute), Cláudio N. Soares(Unknown), Laura M. Fiori(Douglas Mental Health University Institute), Sylvie Dumas(Laboratoire de Neurobiologie Cellulaire et Moléculaire), Rixing Lin(Douglas Mental Health University Institute), Susan Rotzinger(University of Toronto), Jane A. Foster(McMaster University), Naguib Mechawar(Douglas Mental Health University Institute), Eduardo Chachamovich(Douglas Mental Health University Institute), Juan Pablo López(Douglas Mental Health University Institute), Sidney H. Kennedy(University of Toronto), Eduardo Gascon(Centre National de la Recherche Scientifique), Jean‐François Théroux(Douglas Mental Health University Institute), Stéphane Richard‐Devantoy(Douglas Mental Health University Institute), Victor Gorgievski(Délégation Paris 5), Gregory G. Tall(University of Michigan), Corina Nagy(Douglas Mental Health University Institute), Philippe Courtet(Fondation FondaMental), El Chérif Ibrahim(Centre National de la Recherche Scientifique), Eleni T. Tzavara(Inserm), Julien Grenier(Délégation Paris 5)
Cited by 65
Related Papers
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k